Cargando…

Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients

Detalles Bibliográficos
Autores principales:	Sesques, Pierre, Bachy, Emmanuel, Ferrant, Emmanuelle, Safar, Violaine, Gossez, Morgane, Morfin-Sherpa, Florence, Venet, Fabienne, Ader, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786606/ https://www.ncbi.nlm.nih.gov/pubmed/35093212 http://dx.doi.org/10.1016/j.ccell.2022.01.010

Ejemplares similares

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
por: Bourbon, Estelle, et al.
Publicado: (2022)

B-cell malignancies and COVID-19: a narrative review
por: Luque-Paz, David, et al.
Publicado: (2023)

Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient
por: Monneret, Guillaume, et al.
Publicado: (2020)

Sepsis in PD-1 light
por: Monneret, Guillaume, et al.
Publicado: (2016)

Automated bedside flow cytometer for mHLA-DR expression measurement: a comparison study with reference protocol
por: Zouiouich, Mehdi, et al.
Publicado: (2017)

Dysregulated expression of amino-acid and glucose transporters on circulating plasma cells in septic shock patients: a preliminary study
por: Lepage, Margot, et al.
Publicado: (2022)

Delayed persistence of elevated monocytic MDSC associates with deleterious outcomes in septic shock: a retrospective cohort study
por: Waeckel, Louis, et al.
Publicado: (2020)

Intracellular calcium signaling and phospho-antigen measurements reveal functional proximal TCR activation in lymphocytes from septic shock patients
por: de Roquetaillade, Charles, et al.
Publicado: (2019)

Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
por: Remy, Solenn, et al.
Publicado: (2018)

Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies
por: Nicolas, Philippe, et al.
Publicado: (2022)

Immunité cellulaire et humorale anti-SARS-CoV-2 chez les patients SEP traités par anti-CD20
por: Nicolas, Philippe, et al.
Publicado: (2023)

Massive increase in monocyte HLA-DR expression can be used to discriminate between septic shock and hemophagocytic lymphohistiocytosis-induced shock
por: Remy, Solenn, et al.
Publicado: (2018)

Monitoring NLRP3 Inflammasome Activation and Exhaustion in Clinical Samples: A Refined Flow Cytometry Protocol for ASC Speck Formation Measurement Directly in Whole Blood after Ex Vivo Stimulation
por: Coudereau, Rémy, et al.
Publicado: (2022)

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010)

Chimeric antigen receptor T cell: A cancer immunotherapy
por: Singh, Surjit, et al.
Publicado: (2022)

Proof of concept study of mass cytometry in septic shock patients reveals novel immune alterations
por: Gossez, Morgane, et al.
Publicado: (2018)

Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes
por: Leijte, Guus P., et al.
Publicado: (2020)

T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19
por: Venet, Fabienne, et al.
Publicado: (2022)

A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
por: Valton, Julien, et al.
Publicado: (2018)

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
por: Kosti, Paris, et al.
Publicado: (2018)

Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2021)

Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
por: Shin, Seungyong, et al.
Publicado: (2023)

Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in Europe
por: Buechner, Jochen, et al.
Publicado: (2018)

Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management
por: Bal, Antonin, et al.
Publicado: (2018)

TCR activation mimics CD127(low)PD-1(high) phenotype and functional alterations of T lymphocytes from septic shock patients
por: Mouillaux, Julie, et al.
Publicado: (2019)

Characterization of Circulating IL-10-Producing Cells in Septic Shock Patients: A Proof of Concept Study
por: Fabri, Astrid, et al.
Publicado: (2021)

Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T Cells
por: Maher, John
Publicado: (2012)

Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
por: Han, Ethan Q, et al.
Publicado: (2013)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018)

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
por: Yilmaz, Ahmet, et al.
Publicado: (2020)

Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges
por: Toulouie, Sara, et al.
Publicado: (2021)

Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
por: Brown, Kevin, et al.
Publicado: (2021)

Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
por: Fanciulli, Giuseppe, et al.
Publicado: (2022)

2708. Infectious Complications Among CD19 Chimeric Antigen Receptor T-cell Recipients
por: Huggins, Jonathan, et al.
Publicado: (2023)

Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia
por: Saison, Julien, et al.
Publicado: (2014)

Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) Study
por: Peronnet, Estelle, et al.
Publicado: (2023)

Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
por: Shi, Huan, et al.
Publicado: (2014)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
por: Grada, Zakaria, et al.
Publicado: (2013)

A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
por: Zhang, Erhao, et al.
Publicado: (2017)

The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
por: Liu, Dongfang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a482v30k45ngp3a195u57tb6ib